The NHGRI Office of the Clinical Director manages Clinical Support Services for Genetics and Genomics in a variety of ways. 1. The Office provides extensive administrative support for medical personnel in their performance of clinical research into rare genetic diseases. This includes credentialing of health care professionals, support of their state licenses, provision of parking spaces for acute care providers, scheduling of patients and their tests, arranging contracts for clinical testing, and providing reimbursement for travel, outside medical testing, and especially genetic testing. 2. The Office also provides academic support and infrastructure for clinical investigators, including the setting of policies for the Institute, assisting in patient recruitment, handling patient, physician, and Congressional inquiries by phone, FAX, or e-mail, providing advice regarding clinical protocol writing, tracking protocols through the IRB approval system, establishing a Data Safety and Monitoring Board and arranging its meetings twice a year, and creating and maintaining a Statistical Consultation Service for the entire Institute. The Clinical Director also supervises the administrative personnel as well as research nurses and nurse practitioners for the Institute, and schedules ward coverage. The Clinical Director supervises the Bioethics Core and attends IRB meetings. 3. The Office of the Clinical Director advances clinical and translational research in the NHGRI by fostering new initiatives such as the NIH Undiagnosed Diseases Program (in collaboration with the Office of Rare Disease Research and the NIH Clinical Center).

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2011
Total Cost
$6,448,803
Indirect Cost
Name
National Human Genome Research Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Vilboux, Thierry; Doherty, Daniel A; Glass, Ian A et al. (2017) Molecular genetic findings and clinical correlations in 100 patients with Joubert syndrome and related disorders prospectively evaluated at a single center. Genet Med 19:875-882
Bryan, Melanie M; Tolman, Nathanial J; Simon, Karen L et al. (2017) Clinical and molecular phenotyping of a child with Hermansky-Pudlak syndrome-7, an uncommon genetic type of HPS. Mol Genet Metab 120:378-383
Kane, Megan S; Davids, Mariska; Bond, Michelle R et al. (2017) Abnormal glycosylation in Joubert syndrome type 10. Cilia 6:2
Shahrour, M A; Staretz-Chacham, O; Dayan, D et al. (2017) Mitochondrial epileptic encephalopathy, 3-methylglutaconic aciduria and variable complex V deficiency associated with TIMM50 mutations. Clin Genet 91:690-696
Berger, Seth I; Ciccone, Carla; Simon, Karen L et al. (2017) Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variants. Hum Genet 136:409-420
Kambouris, Marios; Thevenon, Julien; Soldatos, Ariane et al. (2017) Biallelic SCN10A mutations in neuromuscular disease and epileptic encephalopathy. Ann Clin Transl Neurol 4:26-35
Christensen, Erik D; Berger, Justin; Alashari, Mouied M et al. (2017) Sudden infant death ""syndrome""-Insights and future directions from a Utah population database analysis. Am J Med Genet A 173:177-182
Ramoni, Rachel B; Mulvihill, John J; Adams, David R et al. (2017) The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease. Am J Hum Genet 100:185-192
Stephen, Joshi; Yokoyama, Tadafumi; Tolman, Nathanial J et al. (2017) Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5. PLoS One 12:e0173682
Oprescu, Stephanie N; Chepa-Lotrea, Xenia; Takase, Ryuichi et al. (2017) Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation. Hum Mutat 38:1412-1420

Showing the most recent 10 out of 71 publications